Results 311 to 320 of about 3,334,579 (366)

Antifungal agents in dermatology

Journal of the American Academy of Dermatology, 1987
Development of new antifungal agents has increased significantly over the past two decades, with recent advances reflecting interest in synthetic agents as opposed to antibiotics. We review the various antifungal medications in use or under development, beginning with a discussion of over-the-counter agents, antibiotics, and older azole compounds and ...
J. Graham Smith, Jack L. Lesher
openaire   +3 more sources

Dermatologic Adverse Events of Systemic Anticancer Therapies: Cytotoxic Chemotherapy, Targeted Therapy, and Immunotherapy.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2020
Over the past 2 decades, rapid advancement in systemic anticancer therapeutics has led to astounding improvement in survival rates of patients with cancer. However, this celebrated progress has brought with it an evolving spectrum of drug toxicities that
A. Deutsch, N. LeBoeuf, M. Lacouture, B. McLellan   +3 more
semanticscholar   +1 more source

Immunosuppressive Agents in Dermatology

Dermatologic Clinics, 1993
Azathioprine, cyclophosphamide, and cyclosporine are immunosuppressive agents commonly used by dermatologists. Azathioprine has a good safety profile and is preferred by most dermatologists for the treatment of bullous pemphigoid, cutaneous vasculitides, chronic eczematous dermatitides, and cutaneous manifestations of connective tissue diseases.
V C, Ho, D M, Zloty
openaire   +2 more sources

Dermatologic adverse events to chemotherapeutic agents, Part 2: BRAF inhibitors, MEK inhibitors, and ipilimumab.

Seminars in cutaneous medicine and surgery, 2014
The advent of novel targeted chemotherapeutic agents and immunotherapies has dramatically changed the arena of cancer treatment in recent years. BRAF inhibitors, MEK inhibitors, and ipilimumab are among the newer chemotherapy drugs that are being used at
Jennifer N. Choi
semanticscholar   +1 more source

IMMUNOSUPPRESSIVE AGENTS IN DERMATOLOGY

Dermatologic Clinics, 1998
Azathioprine, cyclophosphamide, methotrexate, and cyclosporine are the immunosuppressive agents most commonly used by dermatologists. Azathioprine has a relatively good safety profile and is therefore often preferred for the treatment of chronic eczematous dermatitides and bullous disorders.
Vincent C. Ho, Jan P. Dutz
openaire   +3 more sources

Dermatologic adverse events to chemotherapeutic agents, part 1: cytotoxics, epidermal growth factor receptors, multikinase inhibitors, and proteasome inhibitors.

Seminars in cutaneous medicine and surgery, 2014
Dermatologic toxicities have profound effects on patients receiving chemotherapy for cancer treatment. Cytotoxic chemotherapies are associated with a number of nonspecific dermatologic adverse events including alopecia, mucositis, and onychodystrophy ...
R. Kyllo, M. Anadkat
semanticscholar   +1 more source

Cold atmospheric pressure plasmas in dermatology: Sources, reactive agents, and therapeutic effects

, 2020
Recently, cold atmospheric pressure plasmas (CAPs) have provided many new opportunities in dermatology by providing a multimodal action of reactive agents (RA).
Dawei Liu, Yanzhe Zhang, Maoyuan Xu, Hongxiang Chen, Xinpei Lu, K. Ostrikov   +5 more
semanticscholar   +1 more source

Topical Antibacterial Agents in Dermatology

The Journal of Dermatology, 2003
AbstractTopical antibacterials are being widely used for the treatment or prevention of superficial bacterial infections. Emergence of drug resistant mutant strains of microorganisms and development of irritant and allergic contact dermatitis is a common problem with many of the topical antibacterials.
Anjum Singal, Gurvinder P. Thami
openaire   +3 more sources

A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 1.

Dermatitis, 2009
Biologic therapies are an efficacious new method of controlling a number of chronic conditions. Data regarding these medications continues to emerge, giving clinicians a greater understanding of their side effects profiles.
M. Bremmer, A. Deng, A. Gaspari
semanticscholar   +1 more source

Topical hemostatic agents for dermatologic surgery.

The Journal of Dermatologic Surgery and Oncology, 1988
Topical hemostatic agents are very helpful in attaining capillary and small vessel hemostasis in dermatologic surgery. The commonly used topical hemostatic agents, including oxidized cellulose, absorbable gelatin, and thrombin are reviewed, along with ...
P. Larson
semanticscholar   +2 more sources